Ankit Mahadevia

2016

In 2016, Ankit Mahadevia earned a total compensation of $815K as Chief Executive Officer at Spero Therapeutics.

Compensation breakdown

Bonus$108,150
Option Awards$345,125
Salary$360,500
Other$1,210
Total$814,985

Mahadevia received $360.5K in salary, accounting for 44% of the total pay in 2016.

Mahadevia also received $108.2K in bonus, $345.1K in option awards and $1.2K in other compensation.

Rankings

In 2016, Ankit Mahadevia's compensation ranked 9,220th out of 14,075 executives tracked by ExecPay. In other words, Mahadevia earned more than 34.5% of executives.

ClassificationRankingPercentile
All
9,220
out of 14,075
35th
Division
Manufacturing
3,559
out of 5,489
35th
Major group
Chemicals And Allied Products
1,230
out of 1,895
35th
Industry group
Drugs
975
out of 1,538
37th
Industry
Pharmaceutical Preparations
774
out of 1,176
34th
Source: SEC filing on April 27, 2018.

Mahadevia's colleagues

We found one more compensation record of an executive who worked with Ankit Mahadevia at Spero Therapeutics in 2016.

2016

Christina Larkin

Spero Therapeutics

Chief Operating Officer

News

You may also like